1. $CLDX from Like it here

  2. Stocks to Watch for April 21, 2014 http://y.ahoo.it/a2FzJRBZ $AOL $CLDX $FCEL $GRPN $PKT $RMBS $ZNGA

  3. $CLDX Cramer withholds comment on $cdx to caller on his show. Funny ... last year he recommended @ roughly $14. Went to $38. Now no comment?

  4. Updated cost basis for our portfolio: $AA-$12.02, $BLK-$286.92, $CLDX-$17.32, $GE-$26.91, $JNJ-$83.54, $KO-$36.78, $V-$175.95, $XCO-$5.84

  5. Closed the week with these longs: $AA $BLK $CLDX $GE $JNJ $KO $V $XCO

  6. $CLDX Back to 16 next week

  7. $CLDX still holding. Setup looks good for a bounce.

  8. $CLDX indicators are turning up and flashing buy signals. http://y.ahoo.it/8qDSZkPv

  9. $CLDX This was one of Barron s Best Biotechs picks for 2014.

  10. $CLDX 3 posters at ASCO- including Rindo, CDX-011* This is a steal.

  11. $CLDX Not only great buy opportunity for ASCO also near term catalysts ACT IV , ReACT, CDX-1127, 4 positive phase II, 2 positive phase III

  12. $CLDX Celldex s Phase 1 Study of CDX-1401 Published in Science Translational Medic.. http://y.ahoo.it/WSTDzO2P

  13. OXGN Genomics Fund Founder Steven Newby he bought 7,33% from $OXGN who is next ? $OXGN SOAR !! $INO $ATRS $CLDX $OXGN up again

  14. $CLDX ( thanks mark )Near term catalysts & also what a great entry for ASCO- CLDX presenting CDX-1127/ Rindo.

  15. $CLDX ( thanks mark roman ) What a great entry for ASCO- CLDX presenting CDX-1127/ Rindo.

  16. $CLDX @ johnlewis Celldex s Immunity Drug Published in Renowed Known Medical Journal http://y.ahoo.it/dnbIqISH

  17. $CLDX Celldex s Phase 1 Study of CDX-1401 Published in Science Translational Medic.. http://y.ahoo.it/n37Hswv2

  18. $CLDX @markroman What a great entry for ASCO- CLDX presenting CDX-1127/ Rindo.

  19. $CLDX eod rally :)

  20. $CLDX volume picking up fast now. time to go long.

  21. $CLDX Celldex s Immunity Drug Published in Renowed Know Medical Journal http://y.ahoo.it/xGCas6v0

  22. @OphirGottlieb Your take on $CLDX?

  23. $CLDX @ mark Not only great buy for ASCO & near term catalysts ACT IV , ReACT, CDX-1127, 4 positive phase II, 2 positive phase III

  24. $CLDX Article in Renowed Magazine CDX-1401 Data Shows Robust Cellular Immunity. LINK http://y.ahoo.it/JSmihI5c

  25. $CLDX Celldex s Phase 1 Study of CDX-1401 Published in Science Translational Medicine